Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.61 |
| ▸ | ESR1 | P03372 | 1/20 | 0.60 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.60 |
| ▸ | ACP1 | P24666 | 1/20 | 0.60 |
| ▸ | PDE4A | P27815 | 1/20 | 0.60 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.60 |
| ▸ | P2RX2 | Q9UBL9 | 1/20 | 0.60 |
| ▸ | PNPO | Q9NVS9 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 3/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.48 |
| ▸ | AOX1 | Q06278 | 1/20 | 0.48 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.47 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.47 |
| ▸ | PDXK | O00764 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | SGPL1 | O95470 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29040292 | 0.99 | HPGD (0.59) | HPGDKDM4EALDH1A1HSD17B10ESR1 | |
| SCHEMBL8967900 | 0.91 | HPGD (0.61) | HPGDKDM4EALDH1A1HSD17B10ESR1 | |
| SCHEMBL31536462 | 0.89 | HPGD (0.55) | HPGDKDM4EALDH1A1HSD17B10ESR1 | |
| SCHEMBL1005970 | 0.89 | HPGD (0.58) | HPGDKDM4EALDH1A1HSD17B10ESR1 | |
| SCHEMBL43880 | 0.88 | ESR1 (0.64) | HPGDKDM4EALDH1A1HSD17B10ESR1 | |
| SCHEMBL29384180 | 0.88 | ESR1 (0.64) | HPGDKDM4EALDH1A1HSD17B10ESR1 | |
| Ammonia Solution, Strong SCHEMBL31241292 | 0.87 | ESR1 (0.63) | HPGDKDM4EALDH1A1HSD17B10ESR1 | |
| Hydrochloric Acid SCHEMBL14331173 | 0.87 | ESR1 (0.63) | HPGDKDM4EALDH1A1HSD17B10ESR1 | |
| Water SCHEMBL371432 | 0.87 | ESR1 (0.63) | HPGDKDM4EALDH1A1HSD17B10ESR1 | |
| SCHEMBL15342850 | 0.86 | KDM4E (0.58) | HPGDKDM4EALDH1A1HSD17B10ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12421264-B2 | Compounds and methods for the treatment of pathogenic Neisseria | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2025-09-23 | — | — | US | claimed |
| EP-4320094-A1 | NOVEL MODULATORS OF THE MELATONIN RECEPTORS AS WELL AS METHOD OF MANUFACTURE AND USES THEREOF | Cosmas Therapeutics Development Inc. (CA) | 2024-02-14 | — | — | EP | claimed |
| WO-2022213195-A1 | NOVEL MODULATORS OF THE MELATONIN RECEPTORS AS WELL AS METHOD OF MANUFACTURE AND USES THEREOF | COSMAS THERAPEUTICS DEVELOPMENT INC. (CA) | 2022-10-13 | — | — | WO | claimed |
| US-20220089626-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF PATHOGENIC NEISSERIA | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2022-03-24 | — | — | US | claimed |
| US-10655153-B2 | Chemoenzymatic synthesis of peptide beta-lactones and beta-hydroxy acids | WASHINGTON UNIVERSITY (US) | 2020-05-19 | — | — | US | claimed |
| WO-2020051701-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF PATHOGENIC NEISSERIA | INSTITUT NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CA) | 2020-03-19 | — | — | WO | claimed |
| WO-2019169478-A1 | TREATMENT OF PROTEIN AGGREGATION DISEASES USING N,N,N-TRIMETHYLCHITOSAN | OVENSA INC. (CA) | 2019-09-12 | — | — | WO | claimed |
| US-20180265905-A1 | CHEMOENZYMATIC SYNTHESIS OF PEPTIDE BETA-LACTONES AND BETA-HYDROXY ACIDS | WASHINGTON UNIVERSITY (US) | 2018-09-20 | — | — | US | claimed |
| EP-3302059-A1 | SELECTIVE SOLVENT FREE PHOSPHORYLATION | Chromadex, Inc. (US) | 2018-04-11 | — | — | EP | claimed |
| WO-2016196941-A1 | SELECTIVE SOLVENT FREE PHOSPHORYLATION | CHROMADEX, INC. (US) | 2016-12-08 | — | — | WO | claimed |
| US-20070292541-A1 | Method for Producing Organically-Bound Vitamin B | JHS-PRIVATSTIFTUNG (AT) | 2007-12-20 | — | — | US | claimed |
| EP-1867728-A1 | Process for the preparation of a plant enriched with B vitamins | JHS-Privatstiftung (AT) | 2007-12-19 | — | — | EP | claimed |
| EP-0525821-B1 | Methods and structures employing non-radioactive chemically-labeled polynucleotide probes | ENZO BIOCHEM INC (US) | 2006-03-29 | — | — | EP | claimed |
| EP-1009416-A1 | WEIGHT CONTROL COMPOSITION COMPRISING HYPERICUM PERFORATUM | Braswell, A., Glenn (US) | 2000-06-21 | — | — | EP | claimed |
| US-5911992-A | Method for controlling weight with hypericum perforatum and garcinia cambogia | A. GLENN BRASWELL (US) | 1999-06-15 | — | — | US | claimed |
| WO-1998056397-A1 | WEIGHT CONTROL COMPOSITION COMPRISING HYPERICUM PERFORATUM | BRASWELL A GLENN (US) | 1998-12-17 | — | — | WO | claimed |
| EP-0495270-B1 | Azaribine composition | DRELL WILLIAM DR (US) | 1996-01-03 | — | — | EP | claimed |
| EP-0338916-B1 | HAEMOGLOBIN MACROMOLECULAR COMPLEXES, METHOD OF PREPARATION AND THEIR USES | PASTEUR MERIEUX SERUMS ET VACCINS (FR) | 1992-07-01 | — | — | EP | claimed |
| US-4921809-A | Polymer coated solid matrices and use in immunoassays | FINDLEY ADHESIVES, INC. (US) | 1990-05-01 | — | — | US | claimed |
| EP-0312135-A2 | Polymer coated solid matrices and use in immunoassays | FINDLEY ADHESIVES INC. (US) | 1989-04-19 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220089626-A1 | COMPOUNDS AND METHODS FOR THE TREATMENT OF PATHOGENIC NEISSERIA | NMBR, MLEC, BPGM | HPGD 864/4885KDM4E 1724/4885ALDH1A1 2797/4885 |
| US-12421264-B2 | Compounds and methods for the treatment of pathogenic Neisseria | NMBR, MLEC, BPGM | HPGD 864/4885KDM4E 1724/4885ALDH1A1 2797/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.